Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Interest Expenses (2021 - 2025)

PAVmed has reported Interest Expenses over the past 5 years, most recently at $5000.0 for Q4 2025.

  • Quarterly results put Interest Expenses at $5000.0 for Q4 2025, down 28.57% from a year ago — trailing twelve months through Dec 2025 was $21000.0 (down 38.24% YoY), and the annual figure for FY2025 was $21000.0, down 53.33%.
  • Interest Expenses for Q4 2025 was $5000.0 at PAVmed, down from $8000.0 in the prior quarter.
  • Over the last five years, Interest Expenses for PAVM hit a ceiling of $525000.0 in Q3 2022 and a floor of $4000.0 in Q1 2021.
  • Median Interest Expenses over the past 5 years was $16000.0 (2024), compared with a mean of $128533.3.
  • Biggest five-year swings in Interest Expenses: plummeted 95.18% in 2024 and later fell 28.57% in 2025.
  • PAVmed's Interest Expenses stood at $4000.0 in 2021, then surged by 5700.0% to $232000.0 in 2022, then crashed by 91.81% to $19000.0 in 2023, then plummeted by 63.16% to $7000.0 in 2024, then fell by 28.57% to $5000.0 in 2025.
  • The last three reported values for Interest Expenses were $5000.0 (Q4 2025), $8000.0 (Q3 2025), and $4000.0 (Q2 2025) per Business Quant data.